Publicaciones (67) Publicaciones de ANTONIO SÁNCHEZ POZO

2023

  1. Changes in PRC1 activity during interphase modulate lineage transition in pluripotent cells

    Nature communications, Vol. 14, Núm. 1, pp. 180

  2. Epigenetic marks associated with gestational diabetes mellitus across two time points during pregnancy

    Clinical Epigenetics, Vol. 15, Núm. 1

  3. Epigenome wide association study in peripheral blood of pregnant women identifies potential metabolic pathways related to gestational diabetes

    Epigenetics, Vol. 18, Núm. 1

2022

  1. EZH2 endorses cell plasticity to non-small cell lung cancer cells facilitating mesenchymal to epithelial transition and tumour colonization

    Oncogene, Vol. 41, Núm. 28, pp. 3611-3624

  2. Patología molecular

    Síntesis

2021

  1. Pharmacogenetic Predictors of Response to Interferon Beta Therapy in Multiple Sclerosis

    Molecular Neurobiology, Vol. 58, Núm. 9, pp. 4716-4726

2020

  1. Association of ABCB1 and VEGFA gene polymorphisms with breast cancer susceptibility and prognosis

    Pathology Research and Practice, Vol. 216, Núm. 4

  2. The molecular clock protein Bmal1 regulates cell differentiation in mouse embryonic stem cells

    Life Science Alliance, Vol. 3, Núm. 5

2019

  1. Comparative Metabolomics between Mycobacterium tuberculosis and the MTBVAC Vaccine Candidate

    ACS Infectious Diseases, Vol. 5, Núm. 8, pp. 1317-1326

2018

  1. Pharmacogenetic biomarkers of response in Crohn's disease

    Pharmacogenomics Journal, Vol. 18, Núm. 1, pp. 1-13

  2. RNase H2, mutated in Aicardi-Goutières syndrome, promotes LINE-1 retrotransposition

    EMBO Journal, Vol. 37, Núm. 15

2017

  1. ABCB1 gene polymorphisms and response to chemotherapy in breast cancer patients: A meta-analysis

    Surgical Oncology, Vol. 26, Núm. 4, pp. 473-482

2016

  1. ABCB1 C3435T gene polymorphism as a potential biomarker of clinical outcomes in HER2-positive breast cancer patients

    Pharmacological Research, Vol. 108, pp. 111-118

  2. Gene polymorphisms as predictors of response to biological therapies in psoriasis patients

    Pharmacological Research, Vol. 113, pp. 71-80

2015

  1. De novo resistance biomarkers to anti-HER2 therapies in HER2-positive breast cancer

    Pharmacogenomics, Vol. 16, Núm. 12, pp. 1411-1426

  2. Non-HER2 signaling pathways activated in resistance to anti-HER2 therapy in breast cancer

    Breast Cancer Research and Treatment, Vol. 153, Núm. 3, pp. 493-505

2014

  1. Metabolismo de los aminoácidos no esenciales y derivados

    Bioquímica básica: base molecular de los procesos fisiológicos (Elsevier), pp. 277-289

  2. Metabolismo de los nucleótidos

    Bioquímica básica: base molecular de los procesos fisiológicos (Elsevier), pp. 291-303

2011

  1. Exogenous nucleosides modulate expression and activity of transcription factors in Caco-2 cells

    Journal of Nutritional Biochemistry, Vol. 22, Núm. 6, pp. 595-604

2010

  1. Docencia centrada en el aprendizaje

    El estudiante en el sistema "ECTS": innovaciones docentes para clases teóricas y prácticas (Copicentro), pp. 139-146